|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
10
|
|
pubmed:dateCreated |
1995-3-28
|
|
pubmed:abstractText |
Nephrogenic diabetes insipidus (NDI) is a serious side effect of various drugs. Elevated renal prostaglandin E2 levels have been found in patients with lithium-induced NDI and have been implicated in the pathogenesis. We report the case of a patient who developed NDI following treatment with amphotericin B. Prostaglandin levels were elevated. Indomethacin had an antidiuretic effect and normalized prostaglandin levels.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Oct
|
|
pubmed:issn |
0941-0198
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
72
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
769-71
|
|
pubmed:dateRevised |
2004-11-17
|
|
pubmed:meshHeading |
pubmed-meshheading:7865979-Amphotericin B,
pubmed-meshheading:7865979-Diabetes Insipidus, Nephrogenic,
pubmed-meshheading:7865979-Diuresis,
pubmed-meshheading:7865979-Female,
pubmed-meshheading:7865979-Humans,
pubmed-meshheading:7865979-Indomethacin,
pubmed-meshheading:7865979-Kidney,
pubmed-meshheading:7865979-Leukemia, Myelomonocytic, Acute,
pubmed-meshheading:7865979-Middle Aged,
pubmed-meshheading:7865979-Prostaglandins,
pubmed-meshheading:7865979-Tobramycin,
pubmed-meshheading:7865979-Vasopressins
|
|
pubmed:year |
1994
|
|
pubmed:articleTitle |
Indomethacin treatment in amphotericin B induced nephrogenic diabetes insipidus.
|
|
pubmed:affiliation |
I. Medizinische Klinik und Poliklinik, Johannes Gutenberg Universität Mainz, Germany.
|
|
pubmed:publicationType |
Journal Article,
Case Reports
|
